Skip to content

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Merck & Co. logo
Merck & Co.MRK
$272.5M+347%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$39.8M-123%
Cytokinetics logo
CytokineticsCYTK
-$10.94M+25.3%
Mannkind logo
MannkindMNKD
-$10.29M-160%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.65M-85.0%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's change in AR?
Lexicon Pharmaceuticals (LXRX) reported change in AR of $9.4M in Q1 2026.
How has Lexicon Pharmaceuticals's change in AR changed year-over-year?
Lexicon Pharmaceuticals's change in AR increased by 1015.7% year-over-year, from -$1.03M to $9.4M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.